Cyfuse Biomedical KK (TSE:4892) Pre-Tax Income : 円-586.19 Mil (TTM As of Dec. 2023)

Cyfuse Biomedical KK Pre-Tax Income Chart

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial				-201.05	-167.05	-195.91	-169.29	-53.94

Competitive Comparison of Cyfuse Biomedical KK's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Pre-Tax Income falls into.

Cyfuse Biomedical KK Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cyfuse Biomedical KK's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Cyfuse Biomedical KK's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-586.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK  (TSE:4892) Pre-Tax Income Explanation

Cyfuse Biomedical KK's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 4 years, Cyfuse Biomedical KK's highest Pretax Margin was 20.46%. The lowest was -959.20%. And the median was -182.12%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description